Through a partnership between the Department of Defense and the National Cancer Institute (NCI),TRICARE beneficiaries are eligible to participate in Phase II or Phase III NCI-sponsored cancer clinical trials.
 
By recommending these trials, you can offer your TRICARE patients more options for cancer care and greater access to advances in cancer research, prevention and treatment. The trials may be available to TRICARE beneficiaries who have been diagnosed with (or are at an increased risk for developing) cancer.
 
TRICARE beneficiaries in the following plans are eligible to participate: TRICARE Prime, TRICARE Prime Remote, TRICARE Prime Remote for Active Duty Family Members, TRICARE Standard and TRICARE Extra, TRICARE Reserve Select, TRICARE For Life and the US Family Health Plan. Active duty service members also may participate in the NCI trials if they have an approved referral from a military treatment facility primary care manager or a referral approved by the Military Medical Support Office for their branch of the military.
 
If you are treating an eligible TRICARE beneficiary whom you believe would benefit from participation in a Phase II or Phase III NCI trial, encourage him or her to visit the TRICARE Web Site for more information.
 
Prior authorization is required to participate in NCI clinical trials. The NCI Website lists some of the Phase II or Phase III NCI-sponsored clinical trials, but not all of them. Consult the TRICARE South Region Cancer Clinical Trials case manager at 1-800-779-3060 for a complete listing of available Phase II or Phase III trials or before beginning evaluation or any treatment under a clinical trial.